ENDRA Life Sciences Inc. (NDRA)

Market Cap	11.37M
Revenue (ttm)	n/a
Net Income (ttm)	-13.26M
Shares Out	7.48M
EPS (ttm)	-4.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,602
Open	1.33
Previous Close	1.32
Day's Range	1.33 - 1.59
52-Week Range	1.02 - 7.60
Beta	0.80
Analysts	Strong Buy
Price Target	9.00 (+492.11%)
Earnings Date	May 15, 2023

About NDRA

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound t...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 9, 2017
• Employees: 21
• Stock Exchange: NASDAQ
• Ticker Symbol: NDRA

Analyst Forecast

According to one analyst, the rating for NDRA stock is "Strong Buy" and the 12-month stock price forecast is $9.0.

Price Target

$9.0

(492.11% upside)

Analyst Consensus: Strong Buy